Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours

Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldsmith, Christy, Gaya, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2012
Materias:
Tumour Board: Management with Lung Ablation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460596/
https://www.ncbi.nlm.nih.gov/pubmed/23023165
http://dx.doi.org/10.1102/1470-7330.2012.9015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460596/
https://www.ncbi.nlm.nih.gov/pubmed/23023165
http://dx.doi.org/10.1102/1470-7330.2012.9015

Ejemplares similares